# Trial of Volasertib With or Without Azacitidine in Patients With Myelodysplastic Syndromes

> **NCT02721875** · PHASE1 · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 1 (actual)

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **DRUG:** Volasertib
- **DRUG:** Volasertib
- **DRUG:** Azacitidine

## Key facts

- **NCT ID:** NCT02721875
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-04-28
- **Primary completion:** 2016-06-29
- **Final completion:** 2016-07-29
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2018-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02721875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02721875, "Trial of Volasertib With or Without Azacitidine in Patients With Myelodysplastic Syndromes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02721875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*